glp-1 and mcas GLP-1s in with Dr. Tania Dempsey - Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Mast Cell Activation Syndrome (MCAS)

Abstract BACKGROUND: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) offer cardiorenal benefits in diabetes management

Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice

For women dealing with hormone-driven appetite changes, disrupted sleep that triggers hunger, and stress that drives emotional eating, GLP-1s can make adherence to a calorie deficit significantly easier

GLP1R single-nucleotide polymorphisms rs3765467 and rs10305492 affect beta cell insulin secretory capacity and apoptosis through GLP-1

Incapsula incident ID: 386000140078346338-189686444674122639

Biochemical analysis showed that liraglutide normalized corticosterone levels and reduced activation of the hypothalamicpituitaryadrenal (HPA) axis, providing a neuroendocrine correlate for its anxiolytic-like effects